Questcor Pharma (QCOR) Misses Q4 EPS by 3c
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Trade QCOR Now!
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) reported Q4 EPS of $0.12, $0.03 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $29.3 million versus the consensus estimate of $29.97 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Hastings Entertainment (HAST) Posts Q1 Loss of 27c/Share; Comps Down 4.7%
- Qihoo 360 Technology (QIHU) Reports In-Line Q1 EPS; Guides Q2 Sales
Create E-mail Alert Related Categories
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

